Delivery Order SPE2DR25D1021-SPE2DR26FNL7F
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count) valued at $517,676.25. The award is a firm fixed price contract with an ultimate completion date of August 22, 2025, and was competitively awarded with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution hub...
- The Defense Logistics Agency awarded a $22,254 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Atovaquone-Proguanil 250-100 100 tablets. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 29, 2025, and was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count), valued at $6,446.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 27, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count) valued at $11,793.54. The contract employs firm fixed pricing with a completion date of September 26, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Atovaquone-Proguanil 250-100 in a quantity of 100 units, with a ceiling value of $4,882.70. This award utilized firm fixed price pricing and is classified as a non-set-aside competitive procurement. The delivery order is contingent upon completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Atovaquone-Proguanil 250-100 in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $30.9K and is scheduled for completion by September 30, 2025. The contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,790.18 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with completion due by July 31, 2025. This firm fixed-price, non-set-aside contract calls for the delivery of Atovaquone-Proguanil 250-100 mg unit dose packages in quantities of 24, a combination antimalarial medication used primarily for malaria prophylaxis and treatment in military and veteran...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL7FDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). The contract, valued at $2,760.16, represents a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As one of the largest pharmaceutical distributors in the federal market, AmerisourceBergen maintains an extensive contract portfolio with the DLA Medical Supply Chain, consistently delivering medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/30/25 |